Clinical characteristics and treatment with various tyrosine kinase inhibitors in patients with ETV6-ABL1 positive eosinophilia-associated myeloproliferative neoplasms

This article has no abstract
Epistemonikos ID: a69820c79537761662031fcb100f4f3dc38289d5
First added on: Feb 08, 2025